Correction to: Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carflzomib and antiCD38 monoclonal antibodies
Year: 2025
Type: erratum
Abstract: The above is the only instance in the article in which this reference was cited.All reference numbers that follow (references 64-94) in the remaining sections of the article should be incremented by one in the text and the reference list such that there are a total of 95 references.For example, in the section "Patients with high-risk MM," the first sentence, "An area of focus for treatment intensification…", is supported by Derman et al. 2022, which instead of [64] should be [65].
Source: Annals of Hematology
Institutions: University of Alabama at Birmingham Hospital, UAB Medicine, University of Turin, University of Miami, Sylvester Comprehensive Cancer Center, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación del Cáncer, Amgen (Germany), Amgen (United States), University Medical Center Hamburg-Eppendorf
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,590
OpenAlex ID: W4408995365